Maki Mochizuki

Approval lag and loss for biologic-device combination products in Japan and the United States

Introduction The market for drug delivery devices (DDDs), including combination products that integrate pharmaceuticals and medical devices, has expanded rapidly with the increasing use of biopharmaceuticals and growing adoption of self-administration. However, the extent and causes of approval lag and approval loss fo...